The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Adoptive Transfer

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Adoptive Transfer


Psychiatry related information on Adoptive Transfer


High impact information on Adoptive Transfer


Chemical compound and disease context of Adoptive Transfer


Biological context of Adoptive Transfer


Anatomical context of Adoptive Transfer

  • The adoptive transfer of tumor-infiltrating lymphocytes (TIL) expanded in interleukin-2 (IL-2) to mice bearing micrometastases from various types of tumors showed that TIL are 50 to 100 times more effective in their therapeutic potency than are lymphokine-activated killer (LAK) cells [23].
  • Exploiting the adoptive transfer of T or B cells from primed Icosl(-/-) mice, we provided genetic evidence that costimulation through ICOSL was essential for primary but not secondary helper T cell responses and for the control of both T and B cell activities, resulting in T cell-dependent IgG1 production [24].
  • Mice bearing disseminated FBL leukemia were successfully treated by a combination of cyclophosphamide and adoptive transfer of syngeneic immune lymphocytes [25].
  • Adoptive transfer of T and natural killer cells from wild-type mice, but not from interferon (IFN)-gamma-deficient mice, or administration of IFN-gamma at day 1 after stroke greatly decreased the bacterial burden [26].
  • Upon adoptive transfer to nonirradiated secondary recipients, the B10 cells obtained from the repopulated GVH F1 mice induced F1-specific enlargement of the draining popliteal lymph node and enhancement of the IgG formation therein [27].

Associations of Adoptive Transfer with chemical compounds


Gene context of Adoptive Transfer


Analytical, diagnostic and therapeutic context of Adoptive Transfer


  1. Immunotherapy of renal cell carcinoma. Haas, G.P., Hillman, G.G., Redman, B.G., Pontes, J.E. CA: a cancer journal for clinicians. (1993) [Pubmed]
  2. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. Cameron, R.B., Spiess, P.J., Rosenberg, S.A. J. Exp. Med. (1990) [Pubmed]
  3. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein. Das, M.P., Nicholson, L.B., Greer, J.M., Kuchroo, V.K. J. Exp. Med. (1997) [Pubmed]
  4. Differential antitumor immunity mediated by NKT cell subsets in vivo. Crowe, N.Y., Coquet, J.M., Berzins, S.P., Kyparissoudis, K., Keating, R., Pellicci, D.G., Hayakawa, Y., Godfrey, D.I., Smyth, M.J. J. Exp. Med. (2005) [Pubmed]
  5. T cells reactive to an inducible heat shock protein induce disease in toxin-induced interstitial nephritis. Weiss, R.A., Madaio, M.P., Tomaszewski, J.E., Kelly, C.J. J. Exp. Med. (1994) [Pubmed]
  6. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Woo, P.C., Lo, C.Y., Lo, S.K., Siau, H., Peiris, J.S., Wong, S.S., Luk, W.K., Chan, T.M., Lim, W.W., Yuen, K.Y. Clin. Diagn. Lab. Immunol. (1997) [Pubmed]
  7. Adoptive immunotherapy of alcoholism in C57BL/6 mice with splenocytes extracorporeally stimulated with reaferon. Davydova, T.V., Fomina, V.G. Bull. Exp. Biol. Med. (2001) [Pubmed]
  8. Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness. Miyahara, N., Swanson, B.J., Takeda, K., Taube, C., Miyahara, S., Kodama, T., Dakhama, A., Ott, V.L., Gelfand, E.W. Nat. Med. (2004) [Pubmed]
  9. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Youssef, S., Stüve, O., Patarroyo, J.C., Ruiz, P.J., Radosevich, J.L., Hur, E.M., Bravo, M., Mitchell, D.J., Sobel, R.A., Steinman, L., Zamvil, S.S. Nature (2002) [Pubmed]
  10. Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay. Becker, C., Pohla, H., Frankenberger, B., Schüler, T., Assenmacher, M., Schendel, D.J., Blankenstein, T. Nat. Med. (2001) [Pubmed]
  11. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Stark, M.A., Huo, Y., Burcin, T.L., Morris, M.A., Olson, T.S., Ley, K. Immunity (2005) [Pubmed]
  12. CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis. Grewal, I.S., Foellmer, H.G., Grewal, K.D., Wang, H., Lee, W.P., Tumas, D., Janeway, C.A., Flavell, R.A. Immunity (2001) [Pubmed]
  13. Role of natural killer cells in the destruction of circulating tumor emboli. Hanna, N., Fidler, I.J. J. Natl. Cancer Inst. (1980) [Pubmed]
  14. TNF receptor 1-dependent beta cell toxicity as an effector pathway in autoimmune diabetes. Kägi, D., Ho, A., Odermatt, B., Zakarian, A., Ohashi, P.S., Mak, T.W. J. Immunol. (1999) [Pubmed]
  15. Differential sensitivity of T suppressor cell expression to inhibition by histamine type 2 receptor antagonists. Griswold, D.E., Alessi, S., Badger, A.M., Poste, G., Hanna, N. J. Immunol. (1986) [Pubmed]
  16. Protection against adoptive transfer of autoimmune diabetes mediated through very late antigen-4 integrin. Burkly, L.C., Jakubowski, A., Hattori, M. Diabetes (1994) [Pubmed]
  17. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. Dasgupta, S., Zhou, Y., Jana, M., Banik, N.L., Pahan, K. J. Immunol. (2003) [Pubmed]
  18. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. Coyle, A.J., Lloyd, C., Tian, J., Nguyen, T., Erikkson, C., Wang, L., Ottoson, P., Persson, P., Delaney, T., Lehar, S., Lin, S., Poisson, L., Meisel, C., Kamradt, T., Bjerke, T., Levinson, D., Gutierrez-Ramos, J.C. J. Exp. Med. (1999) [Pubmed]
  19. A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response. Lefrançois, L., Olson, S., Masopust, D. J. Exp. Med. (1999) [Pubmed]
  20. Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure. Burne, M.J., Daniels, F., El Ghandour, A., Mauiyyedi, S., Colvin, R.B., O'Donnell, M.P., Rabb, H. J. Clin. Invest. (2001) [Pubmed]
  21. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. Wen, L., Wong, F.S., Burkly, L., Altieri, M., Mamalaki, C., Kioussis, D., Flavell, R.A., Sherwin, R.S. J. Clin. Invest. (1998) [Pubmed]
  22. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. Yung, R., Powers, D., Johnson, K., Amento, E., Carr, D., Laing, T., Yang, J., Chang, S., Hemati, N., Richardson, B. J. Clin. Invest. (1996) [Pubmed]
  23. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Rosenberg, S.A., Spiess, P., Lafreniere, R. Science (1986) [Pubmed]
  24. Costimulation through the inducible costimulator ligand is essential for both T helper and B cell functions in T cell-dependent B cell responses. Mak, T.W., Shahinian, A., Yoshinaga, S.K., Wakeham, A., Boucher, L.M., Pintilie, M., Duncan, G., Gajewska, B.U., Gronski, M., Eriksson, U., Odermatt, B., Ho, A., Bouchard, D., Whorisky, J.S., Jordana, M., Ohashi, P.S., Pawson, T., Bladt, F., Tafuri, A. Nat. Immunol. (2003) [Pubmed]
  25. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes. Greenberg, P.D., Cheever, M.A., Fefer, A. J. Exp. Med. (1981) [Pubmed]
  26. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. Prass, K., Meisel, C., Höflich, C., Braun, J., Halle, E., Wolf, T., Ruscher, K., Victorov, I.V., Priller, J., Dirnagl, U., Volk, H.D., Meisel, A. J. Exp. Med. (2003) [Pubmed]
  27. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells. Pals, S.T., Gleichmann, H., Gleichmann, E. J. Exp. Med. (1984) [Pubmed]
  28. Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action. Hall, B.M., Pearce, N.W., Gurley, K.E., Dorsch, S.E. J. Exp. Med. (1990) [Pubmed]
  29. A natural immunological adjuvant enhances T cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. Khoruts, A., Mondino, A., Pape, K.A., Reiner, S.L., Jenkins, M.K. J. Exp. Med. (1998) [Pubmed]
  30. Prazosin, an alpha 1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Brosnan, C.F., Goldmuntz, E.A., Cammer, W., Factor, S.M., Bloom, B.R., Norton, W.T. Proc. Natl. Acad. Sci. U.S.A. (1985) [Pubmed]
  31. A role for B cells in the development of T cell helper function in a malaria infection in mice. Langhorne, J., Cross, C., Seixas, E., Li, C., von der Weid, T. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  32. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Wan, Y.Y., Flavell, R.A. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  33. Hematologic effects of inactivating the Ras processing enzyme Rce1. Aiyagari, A.L., Taylor, B.R., Aurora, V., Young, S.G., Shannon, K.M. Blood (2003) [Pubmed]
  34. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Roychowdhury, S., May, K.F., Tzou, K.S., Lin, T., Bhatt, D., Freud, A.G., Guimond, M., Ferketich, A.K., Liu, Y., Caligiuri, M.A. Cancer Res. (2004) [Pubmed]
  35. Physiology of natural killer cells. In vivo regulation of progenitors by interleukin 3. Kalland, T. J. Immunol. (1987) [Pubmed]
  36. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Kim, J.H., Kim, H.Y., Kim, S., Chung, J.H., Park, W.S., Chung, D.H. Am. J. Pathol. (2005) [Pubmed]
  37. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. Elliott, E.A., McFarland, H.I., Nye, S.H., Cofiell, R., Wilson, T.M., Wilkins, J.A., Squinto, S.P., Matis, L.A., Mueller, J.P. J. Clin. Invest. (1996) [Pubmed]
  38. Visualization of effective tumor targeting by CD8+ natural killer T cells redirected with bispecific antibody F(ab')(2)HER2xCD3. Scheffold, C., Kornacker, M., Scheffold, Y.C., Contag, C.H., Negrin, R.S. Cancer Res. (2002) [Pubmed]
  39. The male minor transplantation antigen preferentially activates recipient CD4+ T cells through the indirect presentation pathway in vivo. Chen, Y., Demir, Y., Valujskikh, A., Heeger, P.S. J. Immunol. (2003) [Pubmed]
  40. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Kieseier, B.C., Kiefer, R., Clements, J.M., Miller, K., Wells, G.M., Schweitzer, T., Gearing, A.J., Hartung, H.P. Brain (1998) [Pubmed]
  41. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. Kang, H.K., Michaels, M.A., Berner, B.R., Datta, S.K. J. Immunol. (2005) [Pubmed]
WikiGenes - Universities